(Q37798185)

23 August 2017

title

Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review (English)

1 reference

23 August 2017

main subject

Clostridium difficile

0 references

author name string

Marwan S Abougergi

series ordinal

1

1 reference

23 August 2017

John H Kwon

series ordinal

2

1 reference

23 August 2017

publication date

6 October 2010

1 reference

Digestive Diseases and Sciences

23 August 2017

published in

1 reference

23 August 2017

volume

56

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

19-26

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-010-1411-2

23 August 2017

exact match

0 references

cites work

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1411-2

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1411-2

Factors associated with failure of metronidazole in Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1411-2

Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1411-2

Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1411-2

Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate

21 January 2018

1 reference

12 December 2020

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

1 reference

12 December 2020

Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis

1 reference

12 December 2020

Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001

1 reference

12 December 2020

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications

1 reference

12 December 2020

Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A

1 reference

12 December 2020

Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients

1 reference

12 December 2020

Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin

1 reference

12 December 2020

Intravenous immunoglobulin for resistant Clostridium difficile infection

1 reference

12 December 2020

Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

1 reference

12 December 2020

Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.

1 reference

12 December 2020

Severe Clostridium difficile colitis

1 reference

12 December 2020

Cytotoxin and enterotoxin production by Clostridium difficile

1 reference

12 December 2020

Toxin B is essential for virulence of Clostridium difficile

1 reference

12 December 2020

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

1 reference

12 December 2020

Successful treatment of Clostridium difficile colitis with intravenous immunoglobulin

1 reference

12 December 2020

Human antibody response to surface layer proteins in Clostridium difficile infection

1 reference

12 December 2020

Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.

1 reference

12 December 2020

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

1 reference

12 December 2020

Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients

1 reference

12 December 2020

Refractory Clostridium difficile-associated diarrhea.

1 reference

12 December 2020

Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin

1 reference

12 December 2020

Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters

1 reference

12 December 2020

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

1 reference

12 December 2020

Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea

1 reference

12 December 2020

Enzyme-linked immunosorbent assay (ELISA) for antibodies to Clostridium difficile toxins in patients with pseudomembranous colitis and antibiotic-associated diarrhoea

1 reference

12 December 2020

Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins

1 reference

12 December 2020

Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea

1 reference

12 December 2020

Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease: case reports and literature review

1 reference

12 December 2020

Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe

1 reference

12 December 2020

Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters

1 reference

12 December 2020

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

1 reference

12 December 2020

Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea

1 reference

12 December 2020

Effects of Clostridium difficile toxins given intragastrically to animals

1 reference

12 December 2020

Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease

1 reference

12 December 2020

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

1 reference

12 December 2020

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis

1 reference

12 December 2020

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection

1 reference

12 December 2020

Treatment with monoclonal antibodies against Clostridium difficile toxins

1 reference

12 December 2020

Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease

1 reference

12 December 2020

Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile

1 reference

12 December 2020

Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine

1 reference

12 December 2020

Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea

1 reference

12 December 2020

Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice

1 reference

12 December 2020

Relationship between levels of Clostridium difficile toxin A and toxin B and cecal lesions in gnotobiotic mice

1 reference

12 December 2020

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

1 reference

12 December 2020

An epidemic, toxin gene-variant strain of Clostridium difficile

1 reference

12 December 2020

Serum antibody response to toxins A and B of Clostridium difficile

1 reference

12 December 2020

Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea

1 reference

12 December 2020

Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro

1 reference

12 December 2020

Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding

1 reference

12 December 2020

Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature

1 reference

12 December 2020

10.1007/S10620-010-1411-2

Identifiers

DOI

1 reference

23 August 2017

1 reference